Wall Street is buzzing with talk that Amazon soon will swoop down on the $460 billion prescription drug business — an entry that would pit the online powerhouse against locally based drugstore kingpin Walgreens Boots Alliance.
Amazon going after an established company’s core business? What else is new?
This go-around, however, Amazon could find it a lot tougher to be a
disruptor, especially compared with its successful e-commerce triumphs
with books, consumer electronics, digital media and computers.. . . more